← All organizations
Highest phase reached
Phase 2
First clinical trial
Nov 12, 2018Last known activity
Dec 13, 2024
Timeline
2010s
- Jun 1, 2012
HitGen Inc.— Founded
2020s
- Oct 12, 2020
Vernalis— Acquired
Drugs by trial phase (10 distinct, 17 trials)
Phase 3 (0 own, 1 via acquisition)
Phase 2 (1 own, 6 via acquisition)
Indications
Studied for
Subsidiaries (1 direct, 2 total across the full acquisition tree)
Recent trials (4)
- NCT06781567Lead sponsorPhase 2Dec 13, 2024
- NCT04977167Lead sponsorPhase 1Sep 30, 2021
- NCT04998422Lead sponsorPhase 1Sep 1, 2021
- NCT03710915Lead sponsorPhase 1Nov 12, 2018
Details
- Founded
- Chengdu, CN Jun 1, 2012
- Last known activity
- Dec 13, 2024
